PREDICTIVE RISK INTELLIGENCE • STARTING AT 5 LIVES • REPORTS FROM $5,000
THE RISK LAYER BENEFITS HAS BEEN MISSING

See what the renewal has been hiding.

Traditional small-group and ICHRA quotes show price. Choice Benefits reveals the population, medical, prescription and projected-risk signals behind the next funding decision—even for employers starting at five eligible employees.

5–299 life opportunity12-month projected riskHigh-cost exposureSpecialty Rx intelligence
DE-IDENTIFIED ILLUSTRATIVE REPORT

2027 Renewal Intelligence

Strategy gradeA
EMPLOYEES ANALYZED1,060
MATCH CONFIDENCE86.4%
PROJECTED RISK1.08
Demographic risk1.30
Morbidity risk0.83
Projected risk1.08
WHY THIS CHANGES THE MARKET

Enterprise-grade insight—brought downstream.

Risk intelligence has traditionally lived with large, data-rich employers. Choice Benefits makes a decision-ready version practical for small groups under 300—and creates a risk-informed strategy layer that has not historically existed in ICHRA.

5+

Start with five lives

Small employers no longer have to make a funding decision from premium alone.

<300

The overlooked market

Bring population-level intelligence to employers least likely to have an analytics team.

3

Funding paths tested

All Group, CHOICE Only, or a compliant class-based combination.

1

Connected decision

Risk, market pricing, contributions and employee experience in one strategy.

SHORT CASE STUDY

From 1,060 records to one funding decision.

A de-identified workforce review found an older demographic profile, lower measured morbidity, concentrated GLP-1 and specialty-drug exposure, and no members projected above 10× risk. The outcome was a defensible comparison of both risk pools before renewal—not a predetermined answer.

46average age
44.5%age 50+
1.30demographic risk
0.83morbidity risk
1.08projected risk
86.4%match confidence
FROM DATA TO ACTION

Intelligence that changes the recommendation.

Move beyond a static score. Each signal connects to a funding, contribution or care-access decision.

01

Population

Age, geography, households, participation and permitted classes.

02

Medical + Rx

Morbidity, high-cost exposure, conditions and specialty prescriptions.

03

Market economics

Group renewal pressure versus individual-market availability and pricing.

04

Strategy

All Group, CHOICE Only or the strongest compliant combination.

INVESTMENT VALUE CALCULATOR

How little does the report need to uncover?

Model the $5,000 report investment against the employer’s projected healthcare spend.

ESTIMATED DECISION VALUE$0potential annual improvement
Break-even improvement0%
Value after report cost$0
Projected renewal spend$0
Investment per employee$0

Order with the employer quote →
START WITH WHAT YOU HAVE

One census. Any normal format.

Analyze the census locally, then request the authorized secure destination for sensitive files.

Your file is analyzed locally first and is not automatically transmitted.
STARTING INVESTMENT$5,000

Population analysis, authorized Medical + Rx intelligence, market comparison and a decision-ready funding recommendation.

Begin secure order →Schedule an investor or strategy meeting
THE DIFFERENCE IS THE DECISION

Do not choose a funding model from price alone.

Bring risk, market economics and employee choice into the same conversation.

Request the report →